The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in ...

Frequent use of steroid-based treatments for respiratory issues, allergies, and skin conditions can heighten the risk of ...

Symptoms like a stuffy nose, sneezing, and headaches can significantly impact daily life. Nasal sprays are frequently prescribed to alleviate these symptoms, but using them effectively requires ...

As of publication, tree pollen is the main culprit for allergies, and it's in the high range. Even those trees that don't ...

Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 ...

Nasal steroid sprays. Biologics. Surgery ... according to a survey by the Asthma and Allergy Foundation of America (AAFA). In other words, if you feel like your nasal polyp treatment isn ...

Learn how nasal swabs can aid in the diagnosis of asthma in children. Primary indicators of paediatric asthma include chronic respiratory symptoms such as coughing, wheezing, chest tightness ...

During the meeting, ARS Pharmaceuticals will present nine studies showcasing the safety and efficacy of neffy or epinephrine nasal spray, the first FDA-approved needle-free treatment for Type I ...

and he denied hospitalization for asthma. In addition, patient reported increased nasal congestion, postnasal drip and anosmia, despite taking fluticasone nasal spray daily and loratadine daily.

An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first approved for treating asthma in 2021, but new research led by a University ...

“These findings build on the reported efficacy of tezepelumab in patients with severe, uncontrolled asthma and coexisting chronic rhinosinusitis with nasal polyps and suggest that the reduction ...